Association of vascular endothelial growth factor -2578C/A gene polymorphism in chinese patients with colon cancer

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 3, 2011, Pages 117-121

  Zhang, Lin ^a   Zhang, Guohu ^a   Wang, Peihong ^a   Gong, Jiaqing ^a   Cao, Yongkuan ^a   Tang, Lijun ^a  

^a General Hospital of PLA Chengdu Military Area Command   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CHINESE; COLON CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR GROWTH; TUMOR VOLUME;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952159140     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0166     Document Type: Article

References (34)

1. Balasubramanian SP, Brown NJ, Reed MW(2002) Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer 87:1057-1065. (Pubitemid 35418098)
2. Bates DO, Harper SJ (2002) Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39:225-237. (Pubitemid 37490748)
3. Bates DO, Hillman NJ, Pocock TM, et al. (2002a) Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 200:529-530.
4. Bates DO, Hillman NJ, Williams B, et al. (2002b) Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 200:581-597. (Pubitemid 34823050)
5. Dassoulas K, Gazouli M, Rizos S, et al. (2009) Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 48:563-569.
6. Ferrara N (2001) Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280:C1358-C1366. (Pubitemid 32553190)
7. Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795-803. (Pubitemid 37328914)
8. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676. (Pubitemid 36749215)
9. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6. (Pubitemid 20020880)
10. Harada Y, Ogata Y, Shirouzu K (2001) Expression of vascular endothelial growth factor and its receptor KDR (kinase domaincontaining receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer. Int J Clin Oncol 6:221-228. (Pubitemid 33111358)
11. Hofmann G, Langsenlehner U, Renner W, et al. (2008) Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol 134:591-595. (Pubitemid 351422611)
12. Iordache S, Saftoiu A, Georgescu CV, et al. (2010) Vascular endothelial growth factor expression and microvessel density- two useful tools for the assessment of prognosis and survival in gastric cancer patients. J Gastrointest Liver Dis 19:135-139.
13. Ishigami SI, Arii S, Furutani M, et al. (1998) Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 78:1379-1384. (Pubitemid 28495254)
14. Jacobs EJ, Feigelson HS, Bain EB, et al. (2006) Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 8:R22.
15. Jin Q, Hemminki K, Enquist K, et al. (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647-3653. (Pubitemid 40685580)
16. Jubb AM, Hurwitz HI, Bai W, et al. (2006) Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. J Clin Oncol 24:217-227. (Pubitemid 46622051)
17. Kawakami M, Furuhata T, Kimura Y, et al. (2003) Expression analysis of vascular endothelial growth factors and their relationships to lymph node metastasis in human colorectal cancer. J Exp Clin Cancer Res 22:229-237. (Pubitemid 36734181)
18. Kim JG, Chae YS, Sohn SK, et al. (2008) Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 14:62-66.
19. Koukourakis MI, Papazoglou D, Giatromanolaki A, et al. (2004) VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46:293-298. (Pubitemid 39487303)
20. Maltese P, Canestrari E, Ruzzo A, et al. (2009) VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int J Colorectal Dis 24:165-170.
21. Nakasaki T, Wada H, Shigemori C, et al. (2002) Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 69:247-254. (Pubitemid 34259846)
22. Park HM, Hong SH, Kim JW, et al. (2007) Gender-specific association of the VEGF -2578C>A polymorphism in Korean patients with colon cancer. Anticancer Res 27:2535-2539.
23. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533-543. (Pubitemid 33586866)
24. Parkin DM, Bray F, Ferlay J, et al. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108. (Pubitemid 40372904)
25. Perrone G, Vincenzi B, Santini D, et al. (2004) Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer. Cancer Lett 208:227-234. (Pubitemid 38624165)
26. Pokorny RM, Hunt L, Galandiuk S (2000) What's new with tumor markers for colorectal cancer? Dig Surg 17:209-215. (Pubitemid 30429722)
27. Roy H, Bhardwaj S, Yla-Herttuala S (2006) Biology of vascular endothelial growth factors. FEBS Lett 580:2879-2887. (Pubitemid 43729175)
28. Stefanou D, Batistatou A, Kamina S, et al. (2004) Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo 18:155-160. (Pubitemid 38488998)
29. Tzanakis N, Gazouli M, Rallis G, et al. (2006) Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 94:624-630. (Pubitemid 44851925)
30. Vidaurreta M, Sanchez-Munoz R, Veganzones S, et al. (2010) Vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer. Rev Esp Enferm Dig 102: 20-31.
31. Vogelstein B, Fearon ER, Hamilton SR, et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532.
32. Wong MP, Cheung N, Yuen ST, et al. (1999) Vascular endothelial growth factor is up-regulated in the early premalignant stage of colorectal tumour progression. Int J Cancer 81:845-850. (Pubitemid 29249965)
33. Yamamori M, Sakaeda T, Nakamura T, et al. (2004) Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. Biochem Biophys Res Commun 325: 144-150. (Pubitemid 39441172)
34. Yang B, Cross DF, Ollerenshaw M, et al. (2003) Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications 17:1-6. (Pubitemid 36042784)